Hans L. Zaaijer
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Acute hepatitis B infection escaping vaccination: A case report.
Journal: Medicine
Published: August 26, 2025
HBV deferrals and NAT window period: Assessing the impact of 3-month versus 4-month testing delays.
Journal: Transfusion
Published: April 29, 2025
Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial.
Journal: The Lancet. Haematology
Published: February 24, 2025
Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: February 21, 2025
Low rate of hepatitis Delta virus co-infection in first-time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands.
Journal: Transfusion
Published: February 19, 2025
Assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease: a European perspective.
Journal: Blood transfusion = Trasfusione del sangue
Published: March 18, 2024
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re-emergence of syphilis and HIV pre-exposure prophylaxis use.
Journal: Transfusion
Published: February 26, 2024
Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic.
Journal: Scientific reports
Published: December 31, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Journal: Blood advances
Published: September 11, 2023
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors.
Journal: BMC infectious diseases
Published: February 06, 2023
The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
Journal: PloS one
Published: December 07, 2022
Last Updated: 09/26/2026